# A First Time in Human Study of GSK586529 in Healthy Volunteers

> **NCT00703547** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 21 (actual)

## Conditions studied

- Depressive Disorder and Anxiety Disorders

## Interventions

- **DRUG:** GSK586529 capsules
- **DRUG:** GSK586529 tablets
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00703547
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01-28
- **Primary completion:** 2008-04-11
- **Final completion:** 2008-04-11
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2017-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00703547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00703547, "A First Time in Human Study of GSK586529 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00703547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*